Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis
about
Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosisInstitutional tuberculosis transmission. Controlled trial of upper room ultraviolet air disinfection: a basis for new dosing guidelinesTuberculosis vaccines and prevention of infectionTransformative tools for tackling tuberculosisA review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy dataIncreased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbiditySurgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital wardReal-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC)Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus)The ongoing challenge of latent tuberculosisDriving the Way to Tuberculosis Elimination: The Essential Role of Fundamental ResearchTuberculosis vaccines: barriers and prospects on the quest for a transformative toolGr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infectionThe Impact of Ventilation and Early Diagnosis on Tuberculosis Transmission in Brazilian PrisonsFace mask sampling for the detection of Mycobacterium tuberculosis in expelled aerosolsA nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungsCD8+ T cells provide an immunologic signature of tuberculosis in young childrenThe Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosisPredicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutationsThe next 10 years for tuberculosis vaccines: do we have the right plans in place?Latently and uninfected healthcare workers exposed to TB make protective antibodies against Mycobacterium tuberculosis.Animal models of tuberculosis: Guinea pigs.Animal models in tuberculosis research - where is the beef?Transmission and Institutional Infection Control of Tuberculosis.Tuberculosis Infectiousness and Host Susceptibility.Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission.Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis?Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
P2860
Q23909492-D1F27EA7-04D5-48C9-8B41-0AE18BDAD28CQ23918017-6ECBF6CA-A6FE-4185-8541-78A80D956230Q26782022-17D1C624-F8ED-48A9-AE94-62CE1AFDA9C5Q26784084-365D5133-39AD-41C3-845E-7FD922991FCDQ28383049-810049B4-BD3C-4C09-B1E6-E05984C9846CQ28383076-B90C65AA-C568-414C-978C-52770F0FDD63Q28384771-C6C1A09E-C6E9-4655-A0F1-1A788A6FF710Q28384972-61C6E30E-CCD4-483D-837F-212E323250FBQ28386031-E64C0D92-8EFA-4B51-9C72-E5E7082A874BQ28386135-9D54EACD-CAEE-4446-B1CC-42945394FFC3Q28388018-F944C67F-52BD-46FE-B156-B97282834F49Q28390218-453103FD-B419-4F2C-A7AC-B4E6FFA5177DQ28390496-604DC977-E8AF-475A-A5FE-DAA2966191D3Q28390550-2AFE827A-0894-416C-B5A0-380EEA2BDAC9Q28392356-6A5D7CD5-4C72-4322-B5AB-4DEDF6601B78Q28396228-6A5D140D-0A2F-4A56-8B0A-87DF371CD7FAQ28397400-EEF464A9-CA4D-4829-BD66-9507389BEEC9Q28397729-5DE60067-417D-4010-B949-F30D0DF9DE41Q28397752-D36B19A4-EC2D-42F7-B3A3-4982AA4C3B4FQ33659150-1BAFABC8-3016-49C0-9904-76ACC634E6E2Q33719289-4FE05705-C4E2-4C6F-845A-7904C6EDC446Q35663870-71720DDD-1D8C-4D9B-A25D-B4A3BE70E432Q38527417-EC24CDE9-01FE-41BE-9521-2D715543C440Q38570423-AF0BF4F3-DC71-4D48-8ECB-D8954A0DAD1AQ47720001-82CB9804-6F1B-497E-9124-6EE29828A086Q52646359-FAE23C14-C24E-4121-8952-984FA1860956Q55097452-948031D0-3C0E-4307-8B82-C588B24D74E1Q55617820-48B06FF6-9330-458A-B404-D5FA6C3AF104
P2860
Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@ast
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@en
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@en-gb
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@nl
type
label
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@ast
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@en
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@en-gb
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@nl
prefLabel
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@ast
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@en
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@en-gb
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@nl
P2093
P2860
P921
P1433
P1476
Natural infection of guinea pi ...... ly drug-resistant tuberculosis
@en
P2093
Ashwin S Dharmadhikari
David N McMurray
Edward A Nardell
Ian M Orme
Karin Weyer
Kobus Venter
Martie L Van Der Walt
Matsie Mphahlele
Melvin W First
Paul A Jensen
P2860
P2880
P304
P356
10.1016/J.TUBE.2011.03.002
P407
P577
2011-07-01T00:00:00Z